EUTOS for chronic myeloid leukemia shows improved management and dose optimization is required.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000097:blood*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D007755:Laboratories, Hospital / Q000592:standards*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000188:drug therapy*; D010879:Piperazines / Q000008:administration & dosage / Q000097:blood*; D011743:Pyrimidines / Q000008:administration & dosage / Q000097:blood*; D012042:Registries
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate